Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/7/2019
SIETES contiene 92793 citas

 
 
 1 a 20 de 21 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
2. Cita con resumen
Anónimo. Nalmefene approved for reduction of alcohol consumption. European Union. WHO Drug Information 2013;27:27. [Ref.ID 95229]
3. Cita con resumen
Anónimo. A morphine/naltrexone combination (Embeda) for pain. Med Lett Drugs Ther 2010;52:22-3. [Ref.ID 88306]
4.
Becker G, Blum HE. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Lancet 2009;373:1198-206. [Ref.ID 85566]
6.Tiene citas relacionadas Cita con resumen
Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ. Methylnaltrexone for opoid-induced constipation in advances illness. N Engl J Med 2008;358:2332-43. [Ref.ID 84230]
7.Tiene citas relacionadas Cita con resumen
Thomas J, Karver S, Israel RJ. Methylnaltrexone for opioid-induced constipation in advanced illness. The authors reply. N Engl J Med 2008;359:1071. [Ref.ID 83919]
8.Tiene citas relacionadas Cita con resumen
Chappell D, Rehm M, Conzen P. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008;359:1071. [Ref.ID 83918]
9.Tiene citas relacionadas Cita con resumen
Rubiales AS, del Valle Rivero ML. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008;359:1070-1. [Ref.ID 83917]
10.Tiene citas relacionadas Cita con resumen
Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91. [Ref.ID 80570]
11. Cita con resumen
Boddiger D. Fentanyl-laced street drugs "kill hundreds". Lancet 2006;368:569-70. [Ref.ID 77810]
12. Cita con resumen
Boyd ST, Fremming BA. Rimonabant - a selective CB1 antagonist. Ann Pharmacother 2005;39:684-90. [Ref.ID 73540]
13.
Terra SG, Tsunoda SM. Opioid antagonists in the treatment of pruritus from cholestatic liver disease. Ann Pharmacother 1998;32:1228-30. [Ref.ID 42148]
14.
Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, Iaina A. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996;348:1552-4. [Ref.ID 30852]
15. Cita con resumen
McCrea JB, Lo M-W, Tomasko L, Lin C-C, Hsieh JYK, Capra NL, Goldberg MR. Absence of a pharmacokinetic interaction between losartan and hydrochlorothiazide. J Clin Pharmacol 1995;35:1200-6. [Ref.ID 26039]
16. Cita con resumen
Birkett DJ. Pharmacodynamics - the concentration-effect relationship. Australian Prescriber 1995;18:102-4. [Ref.ID 25279]
17.
Anónimo. Naloxone. Prescrire 1995;15:727. [Ref.ID 25152]
19.
Karavokiros KAT, Tsipis GB. Flumazenil: a benzodiazepine antagonist. Drug Intell Clin Pharm 1990;24:976-81. [Ref.ID 15666]
20.
Martin WR. History and development of mixed opioid agonists, partial agonists and antagonists. Br J Clin Pharmacol 1979;7:273S-9S. [Ref.ID 5156]
Seleccionar todas
 
 1 a 20 de 21 siguiente >>